Jin Medical International Ltd. (ZJYL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Jin Medical International...

NASDAQ: ZJYL · Real-Time Price · USD
0.59
0.01 (1.83%)
At close: Oct 03, 2025, 3:16 PM

Jin Medical International Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
22.83M 23.16M 23.5M 26.6M 24.91M 24.76M 24.61M 19.9M 19.98M 19.58M 19.19M 20M 20.82M 20.79M 20.76M 19.6M 18.44M 17.32M
Cost of Revenue
14.48M 14.19M 13.89M 16.64M 16.19M 16.12M 16.05M 13.03M 13.2M 13.01M 12.83M 13.75M 14.67M 14.44M 14.22M 13.07M 11.93M 11.31M
Gross Profit
8.35M 8.98M 9.61M 9.96M 8.72M 8.64M 8.55M 6.87M 6.78M 6.57M 6.36M 6.25M 6.15M 6.35M 6.55M 6.53M 6.51M 6.01M
Operating Income
1.96M 2.8M 3.64M 3.53M 2.87M 3.14M 3.42M 2.88M 2.89M 2.51M 2.13M 1.97M 1.81M 2.22M 2.63M 2.83M 3.02M 2.69M
Interest Income
301.54K 681.59K 1.02M 1.02M 1.07M 384.85K 44.1K 44.16K 159.10 35.06K 69.91K 82.24K 94.58K 76.82K 59.06K 75.62K 92.17K 102.29K
Pretax Income
2.2M 3.19M 4.18M 4.35M 3.89M 3.87M 3.85M 3.33M 3.44M 3.09M 2.74M 2.4M 2.06M 2.47M 2.88M 3.06M 3.23M 2.79M
Net Income
1.79M 2.73M 3.68M 3.85M 3.46M 3.45M 3.43M 3.06M 3.25M 2.98M 2.71M 2.36M 2.02M 2.32M 2.63M 2.75M 2.88M 2.54M
Selling & General & Admin
4.67M 4.52M 4.37M 4.38M 3.77M 3.38M 3M 2.23M 2.08M 2.13M 2.18M 2.18M 2.19M 2.18M 2.16M 2.16M 2.16M 2.02M
Research & Development
1.99M 2.27M 2.25M 2.27M 2.28M 1.99M 2M 1.59M 1.63M 1.76M 1.89M 1.89M 1.89M 1.73M 1.57M 1.45M 1.32M 1.29M
Other Expenses
1.39M 1.05M 1.01M -220.8K -243.85K 81.41K 50.92K 50.92K 50.92K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
8.05M 7.84M 7.63M 6.43M 5.81M 5.46M 5.05M 3.79M 3.6M 3.67M 3.8M 3.99M 4.19M 3.92M 3.66M 3.42M 3.19M 3.11M
Interest Expense
215.06K 215.06K 215.06K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
1.49M 1.3M 1.1M 855.41K 605.89K 529.6K 453.31K 429.89K 406.47K 404.24K 402.01K 425.42K 448.83K 468.91K 489K 449.73K 410.47K 397.78K
Cost & Expenses
20.87M 20.37M 19.86M 23.07M 22M 21.58M 21.1M 16.82M 16.8M 16.69M 16.63M 17.74M 18.85M 18.36M 17.87M 16.5M 15.12M 14.42M
Income Tax Expense
474.43K 619.16K 763.88K 676.1K 518.5K 466.01K 413.53K 281.03K 218.35K 141.53K 64.7K 61.71K 58.71K 161.98K 265.25K 309.84K 354.43K 250.79K
Shares Outstanding (Basic)
156.7M 156.7M 156.56M 156.56M 156.42M 156.42M 155.95M 155.07M 135.23M 135.23M 135.02M 135.02M 135.01M 135.01M 400.14M 400.14M 400.05M 400.05M
Shares Outstanding (Diluted)
156.55M 156.55M 156.55M 156.55M 156.4M 156.4M 155.95M 155.05M 135.22M 135.22M 135M 135M 135M 135M 400M 400M 400M 400M
EPS (Basic)
0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01
EPS (Diluted)
0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01
EBITDA
2.2M 3.04M 3.88M 3.97M 3.31M 3.58M 3.85M 3.15M 3.22M 2.85M 2.49M 2.31M 2.13M 2.56M 2.98M 3.16M 3.35M 3.02M
EBIT
1.96M 2.8M 3.64M 3.69M 3.03M 3.3M 3.57M 2.88M 2.89M 2.51M 2.13M 1.97M 1.81M 2.22M 2.63M 2.83M 3.02M 2.69M
Depreciation & Amortization
249.04K 243.43K 237.82K 287.92K 284.75K 281.96K 279.17K 278.63K 331.37K 346.98K 362.6K 344.65K 326.7K 336.65K 346.61K 335.93K 325.24K 327.58K